Avidity Biosciences chief scientific officer sells shares worth $162,191
The shares were sold at a weighted average price, with prices ranging from $28.59 to $28.63 per share, amounting to a total ...
Avidity Biosciences CFO sells $93,985 in stock
Michael F. MacLean, Chief Financial Officer of Avidity Biosciences, Inc. (NASDAQ:RNA), recently sold shares of the company ...
Yahoo Finance28d
Avidity Biosciences Plans First BLA Submission and Accelerates Commercialization Preparations for Three Rare Muscle Disease Programs in 2025
On track to complete enrollment in del-desiran HARBOR TM Phase 3 and potential registrational del-brax biomarker cohort as well as initiate global pivotal trial for del-brax by mid-2025 Eric ...
Benzinga.com26d
Analyst Expectations For Avidity Biosciences's Future
8 analysts have shared their evaluations of Avidity Biosciences RNA during the recent three months, expressing a mix of bullish and bearish perspectives. In the table below, you'll find a summary ...